As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
An optimal PSA response, defined as ≤0.2 ng/mL, is achieved by approximately 51% of mHSPC patients 6–8 months after treatment with androgen deprivation therapy (ADT) and androgen receptor pathway ...
Debates on researching SCAM frequently hinge on the tension between theoretical plausibility and empirical testing. The central question is this: should interventions that contradict well-established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results